Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
0.6964
-0.0481 (-6.46%)
At close: Oct 19, 2026, 4:00 PM EDT
0.6969
+0.0005 (0.07%)
After-hours: Oct 19, 2026, 7:35 PM EDT
Bluejay Diagnostics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
3.11M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 249.04K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 20.90M |
| WORK Medical Technology Group LTD | 10.72M |
| INVO Fertility | 7.53M |
| Intelligent Bio Solutions | 4.22M |
| IceCure Medical | 3.95M |
| VolitionRx | 2.46M |
| 20/20 Biolabs | 2.04M |
| Co-Diagnostics | 721.39K |
BJDX News
- 6 days ago - Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness - Accesswire
- 13 days ago - Bluejay Diagnostics announces SYMON-II clinical validation study details - TheFly
- 13 days ago - Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock - Accesswire
- 5 weeks ago - Bluejay Diagnostics and Lovell Government partner to access federal healthcare - TheFly
- 5 weeks ago - Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets - GlobeNewsWire
- 2 months ago - Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization - GlobeNewsWire
- 3 months ago - Bluejay Diagnostics completes enrollment in SYMON-II study - TheFly
- 3 months ago - Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study - GlobeNewsWire